Galecto Inc
Change company Symbol lookup
Select an option...
GLTO Galecto Inc
HYPMY Hypera SA
WILC G Willi-Food International Ltd
WTBA West Bancorporation Inc
RGSEQ Real Goods Solar Inc
CVI CVR Energy Inc
OSTK Overstock.com Inc
EGIL Edgetech International Inc
XOM Exxon Mobil Corp
AIV Apartment Investment and Management Co
Go

Health Care : Biotechnology |
Based in Denmark
Company profile

Galecto Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. The Company’s initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2 (LOXL2). The Company is developing GB0139 for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis (IPF), a life-threatening progressive fibrotic disease of the lung. The Company’s product candidate portfolio also includes GB1211, a selective oral galectin-three inhibitor, which is being developed for the treatment of fibrosis related to non-alcoholic steatohepatitis (NASH), and GB2064, a selective oral inhibitor of LOXL2 for the treatment of myelofibrosis, a malignant disease of the bone marrow in which fibrosis reduces the ability to form blood cells.

Closing Price
$5.61
Day's Change
-2.39 (-29.88%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.80
Day's Low
5.53
Volume
(Heavy Day)
Volume:
8,889,381

10-day average volume:
2,184,503
8,889,381
  • Prev Close
    8.00
  • Today's Open
    6.97
  • Day's Range
    5.53-7.80
  • Avg Vol (10-day)
    2.2M
  • Last (time)
    3:59p ET 06/11/21
  • Last (size)
    133
  • 52-Wk Range
    4.50 - 17.99
    LowHigh
  • (11/23/20 - 06/03/21)
    24.62%
  • 90.2%
  • Market Cap
    141.7M
  • Shares Outstanding
    25.3M
  • -1.69
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 60.17
  • (% of float 05/28/21)
    0.62

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.